Mentari at Guggenheim healthcare conference: migraine pipeline takes shape
AI Summary
Mentari's migraine drug-development pipeline was discussed at a Guggenheim healthcare conference. The headline suggests the company is advancing migraine treatments but provides no specific trial or product details.